瑜伽辅助阿片戒断与自主神经调节:一项随机临床试验
这项在印度成瘾医学科病房开展的2臂早期随机临床试验,纳入59例18-50岁阿片使用障碍伴轻中度戒断症状的男性住院患者,在标准丁丙诺啡治疗基础上加用10次45分钟瑜伽课程。结果显示瑜伽组戒断稳定时间显著缩短(中位5天 vs 9天,HR 4.40),心率变异性、焦虑、睡眠潜伏期和疼痛均改善。
要点
- 瑜伽辅助丁丙诺啡治疗使阿片戒断稳定时间从9天缩短至5天(HR 4.40,P<.001)。
- 瑜伽组心率变异性改善显著,副交感活性增加介导了23%的治疗效应。
- 瑜伽组焦虑改善效应量大(ω2=0.28),睡眠潜伏期缩短61分钟,疼痛亦改善。
核心结论
- 在标准丁丙诺啡治疗基础上加用瑜伽可显著加速阿片戒断恢复并改善自主神经调节、焦虑、睡眠和疼痛。
研究设计与样本
- 2臂早期随机临床试验,2023年4月30日至2024年3月31日在印度成瘾医学科住院病房开展,结局评估者和数据分析者设盲。
- 筛查68人,随机59人(瑜伽组30人、对照组29人),均为男性,平均年龄25.6(SD 3.9)岁,COWS评分4-24分。
- 瑜伽组接受14天内10次监督下45分钟瑜伽课程(放松练习、体式、呼吸技术、引导放松)联合标准丁丙诺啡治疗,对照组仅接受标准丁丙诺啡治疗。
主要发现
- 瑜伽组戒断稳定(COWS<4)速度快于对照组,HR 4.40(95%CI 2.40-8.07),P<.001;中位稳定时间瑜伽组5天(95%CI 4-6天)vs 对照组9天(95%CI 7-13天)。
- 瑜伽组心率变异性改善更优,低频功率ω2=0.16、高频功率ω2=0.14、LF/HF比值ω2=0.12,均P<.001。
- 中介分析显示副交感活性增加解释23%的治疗效应(间接HR 1.38,95%CI 1.10-2.03)。
- 瑜伽组焦虑改善显著更优(ω2=0.28,P<.001),睡眠潜伏期缩短61分钟(P=.008),疼痛改善(P=.004)。
关键数值与推荐
- 主要结局为戒断稳定时间(COWS<4)和心率变异性参数,次要结局包括汉密尔顿焦虑量表、睡眠潜伏期和疼痛评分,基线(第1天)和第15天评估。
- 纳入标准:18-50岁阿片使用障碍成人,COWS评分4-24分;排除标准:重度戒断、影响自主神经功能的神经系统疾病、重度精神疾病、近期瑜伽训练。
临床怎么用
- 可将瑜伽作为阿片戒断方案的辅助干预整合入住院戒断流程,以加速恢复并改善自主神经调节、焦虑、睡眠和疼痛。
- 瑜伽干预为14天内10次45分钟监督课程,含放松练习、体式、呼吸技术和引导放松,可与标准丁丙诺啡治疗并行。
局限性
- 样本量较小(59例),为早期随机临床试验。
- 全部参与者为男性,外推至女性人群需谨慎。
- 单中心研究,位于印度成瘾医学科住院病房。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Opioid withdrawal involves sympathetic hyperactivity and reduced parasympathetic tone, which standard pharmacological treatments may not adequately address, contributing to relapse vulnerability. OBJECTIVE: To evaluate yoga as adjuvant therapy to accelerate opioid withdrawal recovery and assess its impact on heart rate variability, anxiety, sleep, and pain. DESIGN, SETTING, AND PARTICIPANTS: This 2-arm, early-stage randomized clinical trial was conducted at an addiction medicine inpatient ward in India from April 30, 2023 to March 31, 2024. The outcome assessors and data analyst were blinded to group allocation. Participants included adults aged 18 to 50 years with opioid use disorder experiencing mild to moderate withdrawal symptoms (Clinical Opiate Withdrawal Scale [COWS] scores 4-24). Exclusion criteria included severe withdrawal, neurological conditions affecting autonomic function, severe psychiatric conditions, and recent yoga training. Of 68 individuals screened, 59 were randomized (30 yoga and 29 control participants). INTERVENTION: Participants in the yoga group received 10 supervised 45-minute sessions during 14 days alongside standard buprenorphine treatment, including relaxation practices, postures, breathing techniques, and guided relaxation. Participants in the control group received standard buprenorphine treatment only. MAIN OUTCOMES AND MEASURES: Co-primary outcomes included time to withdrawal stabilization (COWS score <4) and heart rate variability parameters. Secondary outcomes included anxiety (Hamilton Anxiety Rating Scale), sleep latency, and pain scores. Assessments were conducted at baseline (day 1) and day 15. RESULTS: Fifty-nine participants (59 male [100%]; mean [SD] age, 25.6 [3.9] years) completed intent-to-treat analysis. Participants in the yoga group recovered faster than those in the control group (hazard ratio [HR], 4.40; 95% CI, 2.40-8.07; P < .001), with a median stabilization time of 5 days (95% CI, 4-6 days) for those in the yoga group vs 9 days (95% CI, 7-13 days) for the control group. Participants in the yoga group showed superior heart rate variability improvements with large effects on low frequency (LF) power (ω2 = 0.16), high frequency (HF) power (ω2 = 0.14), and LF/HF ratio (ω2 = 0.12); all effects were statistically significant (P < .001). Mediation analysis showed that increases in parasympathetic activity accounted for 23% of the treatment effect (indirect HR, 1.38; 95% CI, 1.10-2.03). Anxiety reduction was significantly greater among those in the yoga group (ω2 = 0.28; P < .001), with moderate improvements in sleep latency (a 61-minute reduction; P = .008) and pain (P = .004). CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, yoga significantly accelerated opioid withdrawal recovery and improved autonomic regulation, anxiety, sleep, and pain. These findings support integrating yoga into withdrawal protocols as a neurobiologically informed intervention addressing core regulatory processes beyond symptom management. TRIAL REGISTRATION: Clinical Trials Registry of India Identifier: CTRI/2023/04/051302.
引用
- Goutham S, Bhargav H, Holla B, et al. Yoga for Opioid Withdrawal and Autonomic Regulation: A Randomized Clinical Trial. JAMA Psychiatry. 2026. PMID: 41499110. doi:10.1001/jamapsychiatry.2025.3863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。